Oragenics, Inc.

OGEN · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$11-$21-$14-$16
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$2
Stock-Based Comp.$1$1$1$2
Change in WC$1$2-$2$1
Other Non-Cash$0$10-$0$2
Operating Cash Flow-$9-$7-$15-$13
Investing Activities
PP&E Inv.$0-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$1-$0-$0
Financing Activities
Debt Repay.-$1-$1-$1-$1
Stock Issued$7$1$0$29
Stock Repurch.$0$0$0-$6
Dividends Paid$0$0$0-$1
Other Fin. Act.$0$0$0$1
Financing Cash Flow$6$0-$0$23
Forex Effect$0$0$0$0
Net Chg. in Cash-$3-$8-$16$10
Supplemental Information
Beg. Cash$3$11$27$18
End Cash$1$3$11$27
Free Cash Flow-$9-$8-$15-$14